July 8, 2026 · Form 4 insider transaction
Czibere Akos bought 50,000 shares of Aktis Oncology, Inc. at $4.95 per share, a transaction worth $247.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.